NCT04544111
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer treatment 2 active_not_recruiting NCT05024929
Targeted Therapy to Increase RAI Uptake in Metastatic DTC No drug interventions Not Available Not Available recruiting NCT05132205
Radiofrequency Ablation of Papillary Thyroid Microcarcinoma No drug interventions treatment Not Available active_not_recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination with IV DFMO treatment 1 / 2 active_not_recruiting NCT01510002
Prophylactic Central Neck Dissection for Papillary Thyroid Cancer No drug interventions treatment Not Available completed NCT01974284
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma treatment Not Available terminated NCT06325787
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma No drug interventions treatment Not Available completed NCT01441154
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment No drug interventions Not Available Not Available completed NCT04624477
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer No drug interventions Not Available Not Available recruiting NCT06439745
More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated No drug interventions Not Available Not Available completed NCT04948437
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer No drug interventions Not Available Not Available recruiting NCT05545852
A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC No drug interventions treatment Not Available recruiting NCT03470259
Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging diagnostic 1 completed NCT04664413
Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma No drug interventions Not Available Not Available unknown_status NCT06468696
Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients No drug interventions treatment Not Available recruiting NCT03630120
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer treatment 2 terminated NCT02140476
Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy No drug interventions Not Available Not Available unknown_status NCT00001160
Studies on Tumors of the Thyroid Not Available Not Available recruiting NCT05668962
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC treatment 2 recruiting NCT00451880
Study of XL281 in Adults With Solid Tumors treatment 1 completed NCT03899792
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors treatment 1 / 2 recruiting NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05752669
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer. No drug interventions Not Available Not Available recruiting NCT06235814
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial No drug interventions treatment Not Available recruiting NCT04076514
The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma No drug interventions Not Available Not Available unknown_status NCT01723202
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer treatment 2 active_not_recruiting NCT02178345
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer No drug interventions Not Available Not Available completed NCT05766098
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY No drug interventions Not Available Not Available recruiting NCT05873283
Papillary Thyroid Cancer and Central Lymp Node Dissection No drug interventions Not Available Not Available completed NCT02442661
Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer No drug interventions Not Available Not Available completed NCT04129411
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation No drug interventions treatment Not Available active_not_recruiting NCT00668811
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer treatment 2 completed NCT03469011
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. treatment 1 recruiting NCT01100619
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors treatment 1 completed NCT04354324
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma treatment Not Available recruiting NCT03623516
Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014 No drug interventions Not Available Not Available completed NCT04500925
The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience No drug interventions Not Available Not Available completed NCT06133374
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples No drug interventions Not Available Not Available not_yet_recruiting NCT06286631
Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale No drug interventions Not Available Not Available recruiting NCT03906331
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation Not Available Not Available available NCT00984191
Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid No drug interventions diagnostic Not Available unknown_status NCT03359668
CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer No drug interventions diagnostic Not Available completed NCT03889769
Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma No drug interventions Not Available Not Available unknown_status NCT01502410
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer treatment 2 completed NCT06316895
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors treatment 1 / 2 active_not_recruiting NCT02418390
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma No drug interventions treatment Not Available completed NCT04462471
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers treatment 1 completed NCT01659385
Leptin Levels in Papillary Thyroid Cancer No drug interventions Not Available Not Available completed NCT05247476
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. treatment 4 unknown_status NCT06068101
Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer No drug interventions Not Available Not Available completed NCT02952612
Active Surveillance of Papillary Thyroid Microcarcinoma No drug interventions Not Available Not Available unknown_status NCT04411290
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases No drug interventions Not Available Not Available unknown_status NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. treatment 2 / 3 recruiting NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT06254859
Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery No drug interventions Not Available Not Available recruiting NCT04594720
Circulating Biomarkers to Identify Thyroid Cancer No drug interventions Not Available Not Available completed NCT05796960
European Multicenter Study on Surgical Management of Advanced Thyroid Cancer No drug interventions Not Available Not Available recruiting NCT04396912
Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort No drug interventions Not Available Not Available unknown_status